DermTech, Inc.

Constellation Alpha Capital Corp. (Nasdaq: CNAC), sponsored by Constellation Alpha Capital, LLC, was a healthcare-focused special purpose acquisition company that completed its IPO in 2017. The vehicle targeted opportunities in the life sciences and medical technology sectors, ultimately announcing a business combination with DermTech, Inc., a precision dermatology company specializing in genomics-based skin cancer diagnostics. The 10-Q filed on August 13, 2019, under accession number 0001193125-19-219949, reflects the company's financial position during the period surrounding that de-SPAC transaction. The combined entity subsequently traded under the DermTech name following closing. Sign up at SpacDesk for full filing history, sponsor profiles, and deal analytics on CNAC and hundreds of other SPAC transactions.